Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.23 USD | +7.86% | +3.52% | -18.19% |
Apr. 26 | Cytokinetics Appoints Sung Lee as CFO | MT |
Apr. 18 | Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Chief Financial Officer, Effective May 3, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.19% | 1.04B | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : Says More Than 420,000 Doses of Experimental COVID-19 Monoclonal Antibody Treatment Sotrovimab Sold to Date